ATE73997T1 - Verwendung von substituierten benzamiden zur stimulierung der gastromotorik. - Google Patents

Verwendung von substituierten benzamiden zur stimulierung der gastromotorik.

Info

Publication number
ATE73997T1
ATE73997T1 AT89403431T AT89403431T ATE73997T1 AT E73997 T1 ATE73997 T1 AT E73997T1 AT 89403431 T AT89403431 T AT 89403431T AT 89403431 T AT89403431 T AT 89403431T AT E73997 T1 ATE73997 T1 AT E73997T1
Authority
AT
Austria
Prior art keywords
gastromotors
stimulate
substituted benzamides
benzamides
substituted
Prior art date
Application number
AT89403431T
Other languages
English (en)
Inventor
Jacques Acher
Jean-Claude Monier
Jean-Paul Schmitt
Renee Gardaix-Luthereau
Brenda Dr Costall
Robert Dr Naylor
Original Assignee
Delagrange Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delagrange Lab filed Critical Delagrange Lab
Application granted granted Critical
Publication of ATE73997T1 publication Critical patent/ATE73997T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT89403431T 1988-12-14 1989-12-12 Verwendung von substituierten benzamiden zur stimulierung der gastromotorik. ATE73997T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8816433A FR2640139A1 (fr) 1988-12-14 1988-12-14 Application de benzamides substitues comme gastromoteurs
EP89403431A EP0374029B1 (de) 1988-12-14 1989-12-12 Verwendung von substituierten Benzamiden zur Stimulierung der Gastromotorik

Publications (1)

Publication Number Publication Date
ATE73997T1 true ATE73997T1 (de) 1992-04-15

Family

ID=9372914

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89403431T ATE73997T1 (de) 1988-12-14 1989-12-12 Verwendung von substituierten benzamiden zur stimulierung der gastromotorik.

Country Status (9)

Country Link
US (1) US5116857A (de)
EP (1) EP0374029B1 (de)
JP (1) JPH02237928A (de)
AT (1) ATE73997T1 (de)
CA (1) CA2005442A1 (de)
DE (1) DE68901085D1 (de)
DK (1) DK613989A (de)
FR (1) FR2640139A1 (de)
GR (1) GR3004350T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770262B2 (en) * 2000-03-30 2004-08-03 Questcor Pharmaceuticals, Inc. Nasal administration of agents for the treatment of gastroparesis
US6662951B1 (en) * 2000-09-27 2003-12-16 Basic Resources, Inc. Process for extracting and purifying naturally occurring zeolite
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
CA3155873C (en) * 2008-12-22 2024-03-19 Evoke Pharma, Inc. Nasal formulations of metoclopramide
EP3554489A4 (de) 2016-12-15 2020-06-17 Evoke Pharma, Inc. Behandlung von mässiger bis schwerer gastroparese

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281394A (de) * 1961-07-25
CA1082181A (en) * 1976-06-03 1980-07-22 Eric A. Watts Benzamide derivatives
US4188393A (en) * 1977-04-22 1980-02-12 Sandoz Ltd. Treating spastic conditions or relaxing muscles
US4714707A (en) * 1984-01-13 1987-12-22 Rorer Pharmaceutical Corporation Aryl substituted heterocycles for treating gastrointestinal motility dysfunction
AU5063885A (en) * 1984-10-23 1986-05-15 Nastech Pharmaceutical Co., Inc. Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same
GB8519707D0 (en) * 1985-08-06 1985-09-11 Fordonal Sa Chemical compounds
FR2592042B1 (fr) * 1985-12-19 1988-03-25 Ile De France Nouveaux ortho-anisamides, leur procede d'obtention, et leurs applications therapeutiques
CZ284687B6 (cs) * 1986-04-30 1999-02-17 Dainippon Pharmaceutical Co., Ltd. Substituovaný benzamidový derivát, způsob jeho výroby a farmaceutický prostředek na jeho bázi
DE3782651T2 (de) * 1987-06-17 1993-03-25 Delagrange Lab Anwendung von n-(2-(diaethylamino)aethyl)-2-methoxy-4((1-h-4,5-dihydro-2-imidazolyl)amino)-5-chlorobenzamid als anxiolytisches und antipsychotisches mittel.
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides

Also Published As

Publication number Publication date
US5116857A (en) 1992-05-26
JPH02237928A (ja) 1990-09-20
FR2640139A1 (fr) 1990-06-15
DE68901085D1 (de) 1992-04-30
CA2005442A1 (fr) 1990-06-14
EP0374029A1 (de) 1990-06-20
EP0374029B1 (de) 1992-03-25
DK613989D0 (da) 1989-12-06
DK613989A (da) 1990-06-15
GR3004350T3 (de) 1993-03-31

Similar Documents

Publication Publication Date Title
ES2065880T3 (es) Proteina quimicamente modificada y obtencion de la misma.
DE3169160D1 (en) Amino-acids derivatives and their therapeutic use
SE7906722L (sv) Merkaptoacylderivat av substituerade proliner
DK0571471T3 (da) 5-Heteroylindolderivater
DK0502169T3 (da) Piperazinderivater
BR8807266A (pt) Compostos heterociclicos
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
DK429089D0 (da) Alkylbenzylaminer
SE8503207D0 (sv) Pharmacologically active substituted benzamides
ATE73997T1 (de) Verwendung von substituierten benzamiden zur stimulierung der gastromotorik.
ATE76405T1 (de) 2-trifluormethyl-benzimidazole.
ES538339A0 (es) Procedimiento para la obtencion de o-glicosilamidas sustituidas
DK640687A (da) Allylmercaptoacetylsydnoniminer, deres fremstilling og anvendelse
ATE95704T1 (de) Anwendung heterozyklischer derivate zur herstellung von arzneimitteln.
DK440987A (da) Thyroninderivater, deres fremstilling og anvendelse
DK0445013T3 (da) N-Cycloalkylalkylaminer, fremgangsmåde til fremstilling deraf, deres anvendelse som lægemiddel og deres syntese-mellemprodukter
PT90490A (pt) Processo para a preparacao de acidos aromaticos e do dispositivo que os utiliza
PT86852A (pt) Procede de preparation des nouveaux acetamides derives de la dihydro-2,3 phenyl-3 benzofurannone-2
SE8704551D0 (sv) New benzo(g)quinolines
ATE37546T1 (de) Benzoylharnstoffe.